Seven Members Of Las Cruces-Based Prescription Drug Trafficking Ring Facing Federal Charges
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Seven Members Of Las Cruces-Based Prescription Drug Trafficking Ring Facing Federal Charges

Seven Members Of Las Cruces-Based Prescription Drug Trafficking Ring Facing Federal Charges

December 14, 2012
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Carlos A. Briano
Phone Number: 571-324-7093

ALBUQUERQUE, N.M. - A federal grand jury has indicted seven residents of Las Cruces, N.M., on conspiracy and prescription drug trafficking charges, announced U.S. Attorney Kenneth J. Gonzales and Joseph M. Arabit, Special Agent in Charge of the El Paso Field Division of the Drug Enforcement (DEA). 

Michael Garret Schavier, 29, Juan Rubalcava, 39, Michael Frye, 24, Shane Smolik, 24, Carlos Teran, 29, Kyle Mendenhall, 19, and Kristopher Hollingshead, 23, are charged in a 14-count indictment that was filed by a federal grand jury in Las Cruces on Dec. 13, 2012.  The indictment alleges that, between Dec. 2011 and May 2012, the defendants conspired to possess Oxycodone and Adderall with intent distribute in Dona Ana County, N.M.   The indictment also charges members of the conspiracy with possession of Oxycodone and Adderall with intent to distribute.

According to the indictment, the defendants used fraudulent prescriptions to obtain Oxycodone, a painkiller, and Adderall, a stimulant, from pharmacies in Las Cruces and Alamogordo, N.M.  The indictment alleges that, during a six-month period, the defendants fraudulently obtained an aggregate of 2,691 pills of (30 mg), 120 pills of (15 mg), and 390 pills of (30 mg), with the intention of unlawfully distributing the pills.

This morning, the DEA arrested Smolik, Teran and Frye based on the charges in the indictment.  These defendants will make their initial appearances in federal court in Las Cruces on Dec. 17, 2012.

Schavier and Rubalcava previously were arrested on a related-criminal complaint in Sept. 2012.  Schavier is on conditions of release pending trial while Rubalcava is detained pending trial based on findings that he poses a risk of flight.  Schavier is scheduled to be arraigned on the indictment on Jan. 3, 2013.  An arraignment hearing for Rubalcava has yet to be scheduled.

Mendenhall and Hollingshead are in state custody on unrelated charges.  They will be transferred to federal court to face the charges in the indictment.

Connor Ian Smith, 20, an associate of the defendants, was charged in the criminal complaint against Schavier and Rubalcava.  On Dec. 10, 2012, Smith entered a guilty plea to a criminal information charging him with conspiracy to possess of Oxycodone and Adderall with intent to distribute.  Smith remains on conditions of release pending his sentencing hearing, which has yet to be scheduled.

All eight defendants face a maximum penalty of 20 years of imprisonment and a $1 million fine if convicted.  Charges in indictments and criminal complaints are only accusations.  All criminal defendants are presumed innocent unless proven guilty beyond a reasonable doubt.

These cases were investigated by the Tactical Diversion Squad of the El Paso Division of the DEA and the Alamogordo Department of Public Safety, and are being prosecuted by Assistant U.S. Attorney Jessica Cardenas Jarvis of the U.S. Attorney’s Las Cruces Branch Office.  The U.S. Marshals Service, U.S. Border Patrol, and Dona Ana County Sheriff’s Office assisted in today’s arrest operation.

DEA’s Tactical Diversion Squads combine DEA resources with those of federal, state and local law enforcement agencies in an innovative effort to investigate, disrupt and dismantle those suspected of violating the Controlled Substances Act or other appropriate federal, state or local statutes pertaining to the diversion of licit pharmaceutical controlled substances or listed chemicals.

The DEA El Paso Division encourages parents, and their children to visit the following interactive websites at www.justthinktwice.com, www.GetSmartAboutDrugs.com and www.dea.gov.

Download Press Release
Attachments
elp121412.pdf
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Omar Arellano Special Agent in Charge - El Paso
@DEAElPasoDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español